A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Black Rock Health Sciences Trust stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 45,641 shares of BME stock, worth $1.79 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
45,641
Previous 54,605 16.42%
Holding current value
$1.79 Million
Previous $2.23 Million 14.21%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$39.94 - $42.41 $358,022 - $380,163
-8,964 Reduced 16.42%
45,641 $1.91 Million
Q2 2024

Jul 26, 2024

BUY
$38.45 - $40.88 $86,128 - $91,571
2,240 Added 4.28%
54,605 $2.23 Million
Q1 2024

Apr 24, 2024

BUY
$40.6 - $42.71 $91,715 - $96,481
2,259 Added 4.51%
52,365 $2.17 Million
Q4 2023

Feb 09, 2024

BUY
$35.53 - $40.46 $14,567 - $16,588
410 Added 0.83%
50,106 $2.03 Million
Q3 2023

Oct 24, 2023

BUY
$38.98 - $40.9 $26,584 - $27,893
682 Added 1.39%
49,696 $1.95 Million
Q2 2023

Jul 13, 2023

SELL
$39.55 - $42.93 $24,560 - $26,659
-621 Reduced 1.25%
49,014 $1.99 Million
Q1 2023

May 11, 2023

SELL
$39.34 - $43.68 $63,848 - $70,892
-1,623 Reduced 3.17%
49,635 $2.08 Million
Q4 2022

Feb 08, 2023

SELL
$38.85 - $44.88 $108,236 - $125,035
-2,786 Reduced 5.16%
51,258 $2.23 Million
Q3 2022

Oct 17, 2022

SELL
$38.27 - $44.96 $88,327 - $103,767
-2,308 Reduced 4.1%
54,044 $2.1 Million
Q2 2022

Jul 13, 2022

SELL
$39.97 - $46.86 $18,626 - $21,836
-466 Reduced 0.82%
56,352 $2.39 Million
Q1 2022

May 12, 2022

BUY
$41.57 - $48.2 $76,987 - $89,266
1,852 Added 3.37%
56,818 $2.59 Million
Q4 2021

Feb 03, 2022

BUY
$45.5 - $48.62 $10,101 - $10,793
222 Added 0.41%
54,966 $2.67 Million
Q3 2021

Nov 02, 2021

BUY
$47.27 - $49.44 $437,483 - $457,567
9,255 Added 20.35%
54,744 $2.61 Million
Q2 2021

Aug 10, 2021

BUY
$46.22 - $49.63 $285,685 - $306,763
6,181 Added 15.72%
45,489 $2.21 Million
Q1 2021

May 07, 2021

BUY
$44.61 - $50.31 $38,364 - $43,266
860 Added 2.24%
39,308 $1.82 Million
Q4 2020

Feb 04, 2021

BUY
$41.7 - $48.67 $143,573 - $167,570
3,443 Added 9.84%
38,448 $1.83 Million
Q3 2020

Oct 29, 2020

SELL
$40.57 - $44.0 $15,416 - $16,720
-380 Reduced 1.07%
35,005 $1.5 Million
Q2 2020

Jul 27, 2020

BUY
$33.63 - $43.1 $116,292 - $149,039
3,458 Added 10.83%
35,385 $1.44 Million
Q1 2020

May 08, 2020

BUY
$27.7 - $43.99 $55,566 - $88,243
2,006 Added 6.7%
31,927 $1.15 Million
Q4 2019

Feb 04, 2020

BUY
$36.74 - $42.5 $160,774 - $185,980
4,376 Added 17.13%
29,921 $1.27 Million
Q3 2019

Nov 06, 2019

BUY
$37.6 - $39.3 $61,363 - $64,137
1,632 Added 6.82%
25,545 $977,000
Q2 2019

Aug 15, 2019

BUY
$36.0 - $40.32 $115,848 - $129,749
3,218 Added 15.55%
23,913 $0
Q1 2019

May 08, 2019

BUY
$36.43 - $41.0 $33,187 - $37,351
911 Added 4.6%
20,695 $0
Q4 2018

Feb 05, 2019

BUY
$32.3 - $43.99 $9,399 - $12,801
291 Added 1.49%
19,784 $721,000
Q3 2018

Nov 02, 2018

BUY
$38.7 - $42.67 $264,591 - $291,734
6,837 Added 54.02%
19,493 $0
Q2 2018

Aug 10, 2018

BUY
$33.82 - $39.42 $144,039 - $167,889
4,259 Added 50.72%
12,656 $0
Q1 2018

May 09, 2018

BUY
$33.42 - $37.23 $280,627 - $312,620
8,397 New
8,397 $0

Others Institutions Holding BME

About BlackRock Health Sciences Trust


  • Ticker BME
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in r...
More about BME
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.